Products with
Antifungal bioactivity
Cat.No.
|
Product Name
|
BCN1844 |
Malonomicin
|
1. Malonomicin has inhibitory effects on gram-positive organisms. |
BCN1850 |
Antibiotic ZG 1494alpha
|
1. Antibiotic ZG 1494alpha is a novel inhibitor of platelet-activating factor (PAF) acetyltransferase.
2. Antibiotic ZG-1494alpha exhibits antifungal activity against Candida albicans. |
BCN1853 |
Pramanicin
|
1. Pramanicin, an antifungal agent, has vasorelaxant effect, it induces a slow endothelium-dependent relaxation, which could be reversed with the NO synthase inhibitor, L-NOARG .
2. Pramanicin has potent, selective, and irreversible inhibitory effect on the endothelial ,
thus it has potential development into an anti-angiogenic drug.
3. Pramanicin causes an initial slow endothelium-dependent, NO-mediated vascular relaxation, followed by a cytotoxic effect on vascular endothelial cells, eventually resulting in the loss of vasorelaxant function.
4. Pramanicin as a potential apoptosis-inducing small molecule, which acts through a well-defined JNK- and p38-dependent apoptosis signalling pathway in Jurkat T leukemia cells.
5. Pramanicin is an antimicrobial agent . |
BCN1864 |
Xanthobaccin A
|
1. Xanthobaccin A, an antifungal compound, plays a key role in suppression of sugar beet damping-off disease. |
BCN1942 |
Scopoline
|
1. Scopoline, tropinol, ecgonine, and granatoline derivatives are therapeutic agents of the pyrrole and pyridine group.
2. Scopoletin and scopolin can contribute to a cooperative effect causing plant inhibition in the natural environment and therefore be a factor of ecological significance.
3. Scopoline has fungitoxic effects, it is inhibitory to Sclerotinia at similar doses to scopoletin; as scopolin is known to be less phytotoxic than ayapin and scopoletin, its accumulation may well confer head rot resistance with minimal plant damage and might be one of the bases for resistance to Sclerotinia. |